Sasipong, N. (2019). Targeted overexpression of relaxin receptor 1 (RXFP1) with chronic administration of relaxin as a novel inotropic approach for heart failure treatment.
Chicago Style (17th ed.) CitationSasipong, Nuttarak. Targeted Overexpression of Relaxin Receptor 1 (RXFP1) with Chronic Administration of Relaxin as a Novel Inotropic Approach for Heart Failure Treatment. Heidelberg, 2019.
MLA (9th ed.) CitationSasipong, Nuttarak. Targeted Overexpression of Relaxin Receptor 1 (RXFP1) with Chronic Administration of Relaxin as a Novel Inotropic Approach for Heart Failure Treatment. 2019.
Warning: These citations may not always be 100% accurate.